Michael A. Lemp

TearLab Corporation, Inc. engages in the development and marketing of a tear testing platform. Its primary product, the TearLab Osmolarity System, enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. It measures tear film osmolarity for the diagnosis of dry eye disease. The company was founded by Benjamin D. Sullivan in 1996 and is headquartered in Escondido, CA.

OcuSense, Inc. develops in-vitro diagnostics technologies. It engages in developing tests for other ocular surface diseases and measuring biomarkers for diagnosis and management of eye diseases. The company was founded by Eric Donsky and Benjamin D. Sullivan in 2003 and is headquartered in San Diego, CA.

The Schepens Eye Research Institute, Inc. operates as an eye research institute. It offers treatment for macular degeneration, diabetic retinopathy, glaucoma, other types of retinal and optic nerve degenerations and damage, dry eye and eye tissue transplants. The company was founded by Charles L. Schepens in 1950 and is headquartered in Boston, MA.

Massachusetts Eye & Ear Infirmary operates as hospital that provides patient care for disorders of the eye, ear, nose, throat, head and neck. It offers ophthalmology and otolaryngology research services and is a teaching partner of Harvard Medical School. The firm’s programs and services include anesthesiology, ophthalmology, otolaryngology, radiology, Coolidge Clinic laboratory and libraries. The company was founded in 1824 and is headquartered in Boston, MA.

TearLab Research Inc. engages in the development of technologies to enable eye care practitioners to test a range of biomarkers at the point-of-care. The company is headquartered in Escondido, CA.